Atria Wealth Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,582	Closed	-$1M	–	1819
2025 Q1	$1M	Sell	1,582 -152	-9%	-$105K	0.01%	898
2024 Q4	$1.23M	Buy	1,734 +93	+6%	+$78K	0.01%	844
2024 Q3	$1.73M	Sell	1,641 -317	-16%	-$353K	0.02%	691
2024 Q2	$2.06M	Sell	1,958 -22	-1%	-$21.3K	0.02%	616
2024 Q1	$1.91M	Buy	1,980 +9	+0.5%	+$8.56K	0.02%	661
2023 Q4	$1.73M	Buy	1,971 +218	+12%	+$180K	0.02%	652
2023 Q3	$1.44M	Sell	1,753 -28	-2%	-$22K	0.02%	673
2023 Q2	$1.28M	Sell	1,781 -298	-14%	-$230K	0.02%	740
2023 Q1	$1.71M	Buy	2,079 +397	+24%	+$299K	0.03%	593
2022 Q4	$1.21M	Buy	1,682 +216	+15%	+$159K	0.02%	673
2022 Q3	$1.01M	Sell	1,466 -38	-3%	-$23.9K	0.02%	708
2022 Q2	$889K	Sell	1,504 -194	-11%	-$126K	0.02%	746
2022 Q1	$1.19M	Buy	+1,698	New	+$1.07M	0.02%	664